The FDA Announces Two More Antacid Recalls Due to Cancer Risk

Two more companies recalled their ranitidine drugs, generic forms of Zantac, over concerns they may contain a carcinogenic substance.

The FDA Announces Two More Antacid Recalls Due to Cancer Risk
Two more companies recalled their ranitidine drugs, generic forms of Zantac, over concerns they may contain a carcinogenic substance.
Read More